Fighting HPV by learning to talk about the disease
When asked why she¡¯s so passionate about preventing the spread of HPV, Lois Ramondetta, M.D., is quick to answer.
¡°Cancers are horrible, no matter what type or how a person gets them. But nothing is more upsetting than seeing a cancer that¡¯s completely preventable.¡±
Unfortunately, stopping the most common sexually transmitted infection ¡ª one that almost all sexually active men and women will get at some time in their lives...
A call to action in South Texas
Since its introduction in the 1940s, the Pap test has been successfully detecting abnormal cells in the cervix that, if left untreated, could...
E-cigarettes' growing popularity underscores the need for regulation
In April, new federal data was released showing e-cigarette use has tripled among students in middle and high school. We asked MD Anderson...
Researchers work to control cancer¡¯s evasive actions
New findings about regulation of PD-L1, a protein that allows cancer to evade the immune system, have shown therapeutic promise for several cancers, including the most common form of lung cancer.
The PD-L1-based therapies inhibit the protein, but they don¡¯t work for everyone. Now, MD Anderson scientists have uncovered more detail about how PD-L1 is regulated by the tumor suppressor gene p53, allowing non-small cell lung cancer...
A better understanding of a mutation's link to lung cancer
Mutations of the KRAS gene are commonly known to lead to cancer. But deeper understanding of exactly how they do this continues to be explored...
Beyond C-125: Detecting ovarian cancer earlier
Successful ovarian cancer treatment often relies on catching it early. A study at MD Anderson may help point to a new method of detecting...
Harnessing a mushroom¡¯s toxin to kill cancer
For some time, cancer scientists have considered alpha-amanitin, the toxin derived from ¡°death cap¡± mushrooms, as a possible cancer treatment...
Immunotherapy leader receives Pezcoller Foundation award
Cancer scientist James Allison, Ph.D., internationally known for his role in developing a new class of cancer immunotherapies, has been named...